[Lipid pneumonia after aerosol therapy with gomenol in a 4-month-old child].
Decocq
G
G
Dol
L
L
Leroy
D
D
Dagrenat
I
I
Andrejak
M
M
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents; D001623:Betamethasone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008297:Male; D009822:Oils, Volatile / Q000009:adverse effects; D011017:Pneumonia, Lipid / Q000139:chemically induced* / Q000188:drug therapy; D013729:Terpenes / Q000009:adverse effects*
D000305:Adrenal Cortex Hormones; D018927:Anti-Asthmatic Agents; D000900:Anti-Bacterial Agents; D009822:Oils, Volatile; D013729:Terpenes; C013545:gomenol; D001623:Betamethasone; D004205:Cromolyn Sodium
Pneumopathie huileuse après aérosolthérapie associant le gomenol chez un enfant de 4 mois.